BRD4 and lung adenocarcinoma: Further studies showed that JQ1 combined with CK2 inhibitor (CX-4945) could effectively induce the death of lung adenocarcinoma cells and determined the CK2 phosphorylation of BRD4 as a potential target to overcome this cancer resistance (63, 64).